Sunshine Biopharma (SBFM) Debt Ratio (2012 - 2021)

Sunshine Biopharma (SBFM) has reported Debt Ratio for 9 consecutive years, with 0.86 the latest figure, recorded in Q4 2021.

• For the quarter ending Q4 2021, Debt Ratio fell 49.04% year-over-year to 0.86; the trailing twelve-month figure through Dec 2021 stood at 0.86 (down 49.04% YoY), and the FY2021 full-year result was 0.86, down 49.04% from the prior year.
• Debt Ratio slipped to 0.86 in Q4 2021 per SBFM's latest filing, from 1.41 in the prior quarter.
• Across five years, Debt Ratio topped out at 8.06 in Q1 2020 and bottomed at 0.61 in Q3 2018.
• Historically, Debt Ratio has averaged 2.76 across 5 years, with a median of 1.47 in 2017.
• The sharpest annual moves came in 2018 and 2020: Debt Ratio sank 85.94% in 2018, then soared 871.0% in 2020.
• Over 5 years, Debt Ratio stood at 4.32 in 2017, then tumbled by 85.69% to 0.62 in 2018, then surged by 865.41% to 5.97 in 2019, then slumped by 71.67% to 1.69 in 2020, then plunged by 49.04% to 0.86 in 2021.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.86, 1.41, and 1.31 for Q4 2021, Q3 2021, and Q2 2021 respectively.